- Home
- ORMP vs ATLX Comparison
ORMP vs ATLX Comparison
Compare ORMP & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | ATLX |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 92.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | ATLX |
|---|---|---|
| Price | $2.88 | $5.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 260.9K | ★ 546.2K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 838.25 | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $2,000,000.00 | $180,454.00 |
| Revenue This Year | N/A | $22,084.55 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.82 | $3.54 |
| 52 Week High | $3.09 | $8.32 |
Technical Indicators
Market Signals| Indicator | ORMP | ATLX |
|---|---|---|
| Relative Strength Index (RSI) | 71.35 | 49.57 |
| Support Level | $2.38 | $4.50 |
| Resistance Level | $2.99 | $5.15 |
| Average True Range (ATR) | 0.16 | 0.48 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 83.78 | 49.35 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.